Search
forResearch 10 of 1000+
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Crafting Polymeric and Peptidic Hydrogels for Improved Wound Healing
- Advancements and Applications of Injectable Hydrogel Composites in Biomedical Research and Therapy
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Ottawa, Ontario, Canada, February 13–16, 2013
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →